Further supporting a hypoxic response to intrinsically promote T cell anti-tumor responses, T cells made genetically deficient in VHL or the PHD proteins that lead to proteolytic degradation of HIF-1α had increased anti-tumor activity [107, 109]. The gene discussed is VHL; the disease is neoplasm.